Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in Hyperglycemic Acute Ischemic Stroke
NCT04123067Phase 2Terminated
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Sep 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in ischemic stroke, sponsored by Penn State Health Milton S. Hershey Medical Center. Started Sep 2020; status: terminated.
02
Drugs
pioglitazone
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04123067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04123067.